India is Ready to Tackle Any Health Emergencies: J.P. Nadda Discusses HMPV

New Delhi, Jan 6 (NationPress) India’s surveillance network remains vigilant, and the country is ready to respond promptly to any emerging health challenges, Union Health Minister J.P. Nadda stated on Monday, as the count of Human Metapneumovirus (HMPV) cases in the nation surged to five within a single day.

Five children tested positive for the virus in Karnataka (2), Gujarat (1), and Tamil Nadu (2). The affected children are recovering well, with one having been discharged, according to health authorities.

In a video message, Nadda emphasized that the HMPV virus is not a new development.

“It was first identified in 2001 and has been circulating globally for many years. It spreads through the air via respiratory droplets. This illness can impact individuals across all age brackets. The virus is more prevalent during the winter and early spring months,” the Union Minister explained.

The Health Ministry, the Indian Council for Medical Research (ICMR), and the National Centre for Disease Control are closely monitoring the situation in China and neighboring countries, Nadda assured.

“The WHO has acknowledged the situation and will soon provide a report to us. The respiratory virus data available with ICMR and the Integrated Disease Surveillance Programme has also been assessed,” he noted, adding that the nation is prepared to tackle any health challenges swiftly.

“There is no reason for concern. We are diligently observing the situation,” he reiterated.

According to former ICMR scientist Dr. Raman Gangakhedkar, HMPV is certainly not lethal, and there is currently no evidence indicating severe transmission rates or mortality.

“We can confidently say HMPV is not deadly. Most infections are mild, particularly in children under five and individuals over 65. Symptoms resemble those of a common cold and may last for 4 to 5 days,” Gangakhedkar informed IANS.

“The virus may lead to pneumonitis-like illness, but mortality rates remain largely unknown. HMPV has a global prevalence of approximately 4 percent,” he added.